BioSpace News Archive

HealthTrust announced it has added two more mission-critical drugs – Diprivan® and heparin – to its proprietary pharmacy-contracting model, which is designed to help ease the impact of supply interruptions of essential medications for member hospitals.

Gladstone researchers Warner C. Greene and Eytan Herzig collaborated with Xyphos Biosciences, Inc., to develop a novel immunotherapy for HIV.

Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine.

Today at Dreamforce, Deloitte announced the launch of ConvergeHEALTH Connect powered by Salesforce Health Cloud. ConvergeHEALTH Connect is a suite of products and services designed to help public and private sector health care institutions deliver consistent, high-touch, personalized patient care.

November is Veterans month commemorating the thousands of lives lost and the even greater number injured in wars around the world.

Pharmacies not only have experienced increases in the frequency and total cost of DIR fees, but they also have seen a shift from flat-fee to percentage-based DIRs.

The Image Gently® and Image Wisely® awareness campaigns, radiology and industry collaboration to advance low-dose technologies, growing use of the ACR Dose Index Registry, and mandatory accreditation of imaging facilities under Medicare are among the primary factors that produced a 15-20 percent reduction in medical radiation dose that Americans receive.

DUBLIN, Ireland and BRIDGEWATER, N.J., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused on improving cardiovascular health, announced today that John F. Thero, president and chief executive officer of Amarin, has been named EY’s 2019 Entrepreneur of The Year National Award® for Life Sciences. The global business leader awards program, founded in 1986, recognizes entrepreneurs who are excelling in areas such as innovation, financial perfor

No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that.

Shipman will build new technologies to understand the development of the brain.